Pharmaceutical Ingredients, Active Pharmaceutical Ingredients
Troxerutin, Diosmin, Animal and Plant Extracts, Pharmaceutical Intermediates, Rutin-based Cardiovascular Drugs, Rutin, Plant Flavonoid Capillary Drugs, Plant-derived Anti-tumor Drugs, Plant Flavonoids, Anti-tumor Drugs
Sichuan Xieli Pharmaceutical Co., Ltd., founded in 1980, specializes in the cultivation of ecological medicinal materials, extraction of natural active ingredients from animals and plants, and the synthesis and research of their derivatives. The company produces high value-added export products, including cardiovascular and cerebrovascular drugs based on rutin, plant flavonoid capillary drugs, plant-derived anti-tumor drugs, animal and plant extracts, and pharmaceutical intermediates. With 27 national drug registration approvals, the company has passed certifications from the US FDA, EU GMP, and Japan GMP, exporting to nearly 50 countries and regions worldwide. Xieli is committed to sustainable development, corporate governance, and social responsibility, actively participating in community welfare and environmental protection initiatives.
